We are live on ! Find out more
BCLI

BRAINSTORM CELL THERAPUTC
BCLI

Delisted

BCLI was delisted on the 17th of July, 2025.

Back to rankings

43 hedge funds and large institutions have $8.85M invested in BRAINSTORM CELL THERAPUTC in 2019 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 3

10% more funds holding

Funds holding: 39 → 43 (+4)

7% more capital invested

Capital invested by funds: $8.24M → $8.85M (+$609K)

0% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 10

0.02% less ownership

Funds ownership: 0.63% → 0.61% (-0.02%)

82% less call options, than puts

Call options by funds: $244K | Put options by funds: $1.38M

Holders
43
Holders Change
+4
Holders Change %
+10.26%
% of All Funds
0.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
10
Reduced
10
Closed
3
Calls
$244K
Puts
$1.38M
Net Calls
-$1.13M
Net Calls Change
+$978K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$142K
2
RJA
Raymond James & Associates
Florida
+$135K
3
BlackRock
BlackRock
New York
+$120K
4
Citadel Advisors
Citadel Advisors
Florida
+$47.3K
5
CG
CFO4Life Group
Texas
+$46.4K

Top Sellers

Rank Fund Capital Flow
1
Group One Trading
Group One Trading
Illinois
-$315K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$128K
3
CPP
Crow Point Partners
Massachusetts
-$104K
4
VF
Virtu Financial
New York
-$51K
5
WG
Winton Group
United Kingdom
-$46.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
26
Wells Fargo
California
$21K – – –
First Manhattan
27
First Manhattan
New York
$17K – – –
KPW
28
Kore Private Wealth
New York
$17K +$15.5K +267 New
Deutsche Bank
29
Deutsche Bank
Germany
$15K +$13.6K +235 New
SPIA
30
Steward Partners Investment Advisory
New York
$14K +$3.83K +66 +40%
Citigroup
31
Citigroup
New York
$12K -$812 -14 -7%
UBS Group
32
UBS Group
Switzerland
$11K – – –
Bank of Montreal
33
Bank of Montreal
Ontario, Canada
$9K – – –
IFAM
34
Institutional & Family Asset Management
Colorado
$9K – – –
JP Morgan Chase
35
JP Morgan Chase
New York
$9K +$7.77K +134 New
Fidelity Investments
36
Fidelity Investments
Massachusetts
$6K -$5.16K -89 -48%
ASN
37
Advisory Services Network
Georgia
$2K – – –
VFA
38
Valeo Financial Advisors
Indiana
$2K – – –
KFS
39
Kelly Financial Services
Massachusetts
$1.43K – – –
US Bancorp
40
US Bancorp
Minnesota
$1K – – –
LTFS
41
Ladenburg Thalmann Financial Services
Florida
$1K +$754 +13 New
CPP
42
Crow Point Partners
Massachusetts
– -$104K -1,789 Closed
VF
43
Virtu Financial
New York
– -$51K -867 Closed
HighTower Advisors
44
HighTower Advisors
Illinois
– -$40K -684 Closed
SFS
45
Sowell Financial Services
Arkansas
– +$406 +7 New
1
2

BCLI Hedge Fund Activity: Q4 2019 in Review

43 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in BRAINSTORM CELL THERAPUTC (BCLI) for Q4 2019, worth a combined $8.85M — up 7.4% from $8.24M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new BCLI positions and 3 closed out — a net gain of 4 holders — while 10 added to existing stakes and 10 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $142K. The largest seller was Group One Trading, cutting an estimated $315K.

  • 43 institutional investors held BRAINSTORM CELL THERAPUTC (BCLI) as of Q4 2019, up from 39 in Q3 2019.
  • Funds reported $8.85M of BRAINSTORM CELL THERAPUTC stock for Q4 2019, up 7.4% quarter-over-quarter.
  • 7 funds opened new BRAINSTORM CELL THERAPUTC positions in Q4 2019 and 3 closed out, a net change of +4 holders.
  • The largest BRAINSTORM CELL THERAPUTC buyer in Q4 2019 was Renaissance Technologies, an estimated $142K added.
  • The largest BRAINSTORM CELL THERAPUTC seller in Q4 2019 was Group One Trading, an estimated $315K sold.

Based on aggregated 13F filings for Q4 2019.